IP Library › Granted Patent US 11,202,765
Granted Patent B2
US 11,202,765 · App. 16/039,230 · Granted Dec 21, 2021

Multifunctional topical cream comprising beta-caryophyllene, essential oils, in a phospholipid and triglyceride base

Inventor: John Enrique Mata (Corvallis, OR)
Assignee: John Enrique Mata
A61K31/015A61K9/0014A61K9/06A61K47/14A61K47/24A61K47/44
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,202,765
App. No.
16/039,230
Granted
Dec 21, 2021
Kind
B2
Abstract

A novel pharmaceutical composition is provided comprising beta-caryophyllene or a functionally equivalent derivative, analogue or pharmaceutically acceptable salt thereof in a base cream comprising triglycerides, phospholipid, water, wax, alcohol, with other minor constituents. The composition is useful to treat pain and/or inflammation, reduce fine lines and wrinkles, moisturize, and protect skin with anti-bacterial, anti-fungal and insect repelling properties.

Claims (16)

1. A pharmaceutical composition, comprising:

a) an effective amount of beta-caryophyllene and one or more adjuvants,

b) wherein the effective amount of beta-caryophyllene is in a range from about 50.0 mg/ml to about 150 mg/ml, and

c) wherein the one or more adjuvants comprise:

i) 600 grams shea butter,

ii) 2 grams white bees wax,

iii) 150 ml EtOH,

iv) 150 ml H 2 O,

v) 0.5 ml tea tree oil,

vi) 20 grams Lecithin,

vii) 20 ml PEG,

viii) 10 ml apricot kernel oil, and

ix) 0.5 ml lemon grass oil.

2. The composition of claim 1 , further comprising 3 ml of Unsaponifiable fraction of Olive Oil.

3. A method of treating pain or inflammation of the skin of a mammal comprising topically administering to the skin of the mammal the composition of claim 1 .

4. The method of claim 3 , wherein the mammal is a human.

Continuity (1)
Related Publication 20200030252A1 · Jan 30, 2020